Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 30 10 2018
accepted: 21 01 2019
entrez: 26 2 2019
pubmed: 26 2 2019
medline: 26 2 2020
Statut: epublish

Résumé

Toll-like receptors (TLRs) are pattern-recognition receptors that detect a wide variety of microbial pathogens for the initiation of host defense immunological responses. Thirteen TLRs have been identified in mammals, and teleosts contain 22 mammalian or non-mammalian TLRs. Of these, TLR9 and TLR21 are the cytosine-phosphate-guanosine-oligodeoxynucleotides (CpG-ODNs) recognition TLRs in teleosts. TLR9 is a mammalian TLR expressed in teleost but not in the avian species. TLR21 is a non-mammalian TLR expressed in both teleost and the avian species. Synthetic CpG-ODNs are potent immunostimulants that are being studied for their application against tumors, allergies, and infectious diseases, and as a vaccine adjuvant in humans. The immunostimulatory effects of CpG-ODNs as vaccine adjuvants and their antimicrobial function in domestic animals and teleosts are also being investigated. Most of our current knowledge about the molecular basis for the immunostimulatory activity of CpG-ODNs comes from earlier studies of the interaction between CpG-ODN and TLR9. More recent studies indicate that in addition to TLR9, TLR21 is another receptor for CpG-ODN recognition in teleosts to initiate immune responses. Whether these two receptors have differential functions in mediating the immunostimulatory activity of CpG-ODN in teleost has not been well-studied. Nevertheless, the existence of two recognition TLRs suggests that the molecular basis for the immunostimulatory activity of CpG-ODN in teleosts is different and more complex than in mammals. This article reviews the current knowledge of TLR9 and TLR21 activation by CpG-ODNs. The key points that need to be considered for CpG-ODNs as immunostimulants with maximum effectiveness in activation of immune responses in teleosts are discussed. This includes the structure/activity relationship of CpG-ODN activities for TLR9 and TLR21, the structure/functional relationship of these two TLRs, and differential expression levels and tissue distributions for these two TLRs.

Identifiants

pubmed: 30800129
doi: 10.3389/fimmu.2019.00179
pmc: PMC6375897
doi:

Substances chimiques

Adjuvants, Immunologic 0
CPG-oligonucleotide 0
Hepatitis B Vaccines 0
Oligodeoxyribonucleotides 0
Toll-Like Receptor 9 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

179

Références

Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):87-101
pubmed: 16750571
Fish Shellfish Immunol. 2016 Nov;58:116-124
pubmed: 27629917
Front Immunol. 2018 Mar 16;9:516
pubmed: 29616030
Dev Comp Immunol. 2017 Aug;73:163-168
pubmed: 28359672
Fish Shellfish Immunol. 2014 Feb;36(2):417-27
pubmed: 24378677
Eur Cytokine Netw. 2000 Sep;11(3):362-71
pubmed: 11022119
Nat Immunol. 2004 May;5(5):503-7
pubmed: 15064760
Fish Shellfish Immunol. 2017 Oct;69:247-257
pubmed: 28860075
J Control Release. 2004 May 31;97(1):1-17
pubmed: 15147800
Annu Rev Cell Dev Biol. 2006;22:409-37
pubmed: 16822173
FEBS Lett. 2017 Oct;591(20):3167-3181
pubmed: 28686285
J Immunol. 2011 Jan 15;186(2):649-56
pubmed: 21209287
J Virol. 2003 Nov;77(21):11471-9
pubmed: 14557632
J Natl Cancer Inst. 1984 Apr;72(4):955-62
pubmed: 6200641
J Immunol. 2009 Feb 15;182(4):1836-45
pubmed: 19201835
Sci Rep. 2018 Feb 23;8(1):3565
pubmed: 29476080
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):588-93
pubmed: 9435236
Gene. 2014 Dec 15;553(2):105-16
pubmed: 25300254
J Leukoc Biol. 2002 May;71(5):837-44
pubmed: 11994509
Int J Nanomedicine. 2012;7:2181-95
pubmed: 22619554
Expert Rev Vaccines. 2014 Jul;13(7):909-25
pubmed: 24855906
Cell Tissue Res. 2011 Jan;343(1):121-30
pubmed: 20809414
Immunogenetics. 2005 Jan;56(10):743-53
pubmed: 15578175
Eur J Immunol. 2001 Nov;31(11):3388-93
pubmed: 11745357
Annu Rev Immunol. 2002;20:709-60
pubmed: 11861616
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20711-6
pubmed: 24282308
Expert Rev Vaccines. 2005 Feb;4(1):51-62
pubmed: 15757473
J Immunol. 2002 Feb 15;168(4):1533-7
pubmed: 11823477
Nature. 2000 Dec 7;408(6813):740-5
pubmed: 11130078
Virusdisease. 2014 Jan;25(1):1-17
pubmed: 24426306
Nat Rev Immunol. 2007 May;7(5):353-64
pubmed: 17457343
Science. 2004 Mar 5;303(5663):1526-9
pubmed: 14976262
Mol Immunol. 2005 May;42(9):1057-71
pubmed: 15829296
Fish Shellfish Immunol. 2018 Jun;77:71-82
pubmed: 29567135
Mol Immunol. 2009 May;46(8-9):1710-7
pubmed: 19272649
Cell Mol Life Sci. 2008 Jul;65(13):2091-104
pubmed: 18535781
Adv Hematol. 2012;2012:159807
pubmed: 22811714
Fish Shellfish Immunol. 2015 Aug;45(2):940-5
pubmed: 26093204
Fish Shellfish Immunol. 2013 Sep;35(3):993-7
pubmed: 23742868
Biochem Soc Trans. 2007 Dec;35(Pt 6):1504-7
pubmed: 18031254
Curr Opin Struct Biol. 2017 Dec;47:52-59
pubmed: 28600980
Immunogenetics. 2004 May;56(2):122-33
pubmed: 15107952
Dev Comp Immunol. 2008;32(9):1041-9
pubmed: 18395255
Int Immunol. 2001 Jul;13(7):933-40
pubmed: 11431423
J Immunol. 2008 Sep 1;181(5):3474-85
pubmed: 18714020
Trends Immunol. 2003 Oct;24(10):528-33
pubmed: 14552836
Nature. 1999 Oct 21;401(6755):811-5
pubmed: 10548109
Fish Shellfish Immunol. 2017 Sep;68:327-331
pubmed: 28732767
Mol Immunol. 2004 Jan;40(11):773-83
pubmed: 14687934
Fish Shellfish Immunol. 2014 Dec;41(2):380-8
pubmed: 25241605
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13766-71
pubmed: 11095740
Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40
pubmed: 11763350
Nat Rev Immunol. 2013 Jun;13(6):453-60
pubmed: 23681101
J Exp Med. 2003 Oct 6;198(7):1043-55
pubmed: 14517278
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Annu Rev Immunol. 2002;20:197-216
pubmed: 11861602
Nature. 2001 Oct 18;413(6857):732-8
pubmed: 11607032
Nature. 2001 Apr 26;410(6832):1099-103
pubmed: 11323673
J Immunol. 2002 May 1;168(9):4531-7
pubmed: 11970999
Vet Immunol Immunopathol. 2003 Jan 30;91(2):89-103
pubmed: 12543546
Annu Rev Pharmacol Toxicol. 2003;43:609-28
pubmed: 12540749
Gene. 1999 Apr 29;231(1-2):59-65
pubmed: 10231569
Springer Semin Immunopathol. 2000;22(1-2):21-33
pubmed: 10944797
J Natl Cancer Inst. 1985 Mar;74(3):681-8
pubmed: 3856070
Nucleic Acids Res. 1991 Feb 25;19(4):747-50
pubmed: 1850122
Springer Semin Immunopathol. 2000;22(1-2):11-9
pubmed: 10944796
PLoS One. 2014 Sep 30;9(9):e108808
pubmed: 25269083
Adv Drug Deliv Rev. 2009 Mar 28;61(3):195-204
pubmed: 19211030
Oligonucleotides. 2010 Apr;20(2):93-101
pubmed: 20384481
Fish Shellfish Immunol. 2016 Dec;59:179-188
pubmed: 27751918
Dev Comp Immunol. 2016 Sep;62:102-7
pubmed: 27155354
J Biol Chem. 1999 Jun 18;274(25):17406-9
pubmed: 10364168
Fish Shellfish Immunol. 2013 Oct;35(4):1079-85
pubmed: 23872471
Fish Shellfish Immunol. 2009 Jan;26(1):29-32
pubmed: 18992348
J Immunol. 2018 Jan 15;200(2):573-585
pubmed: 29229676
J Exp Med. 2001 Sep 17;194(6):863-9
pubmed: 11561001
BMC Genomics. 2008 Feb 01;9:62
pubmed: 18241342
Vaccine. 2017 Jun 27;35(30):3691-3699
pubmed: 28579234
Immunity. 2016 Oct 18;45(4):705-707
pubmed: 27760331
Biochim Biophys Acta. 2001 Mar 19;1518(1-2):157-61
pubmed: 11267672
Expert Rev Vaccines. 2011 Apr;10(4):499-511
pubmed: 21506647
Curr Top Microbiol Immunol. 2002;270:63-79
pubmed: 12467244
JAMA. 2018 Feb 27;319(8):822-823
pubmed: 29486033
Fish Shellfish Immunol. 2013 Dec;35(6):1740-50
pubmed: 23507338
Dev Comp Immunol. 2016 Jul;60:218-27
pubmed: 26972738
Sci Rep. 2017 Dec 11;7(1):17297
pubmed: 29229937
Front Immunol. 2018 Jul 02;9:1523
pubmed: 30034391
Eur J Immunol. 2004 Jan;34(1):251-62
pubmed: 14971051
Dev Comp Immunol. 2008;32(6):603-7
pubmed: 18068763
Trends Immunol. 2005 Sep;26(9):469-76
pubmed: 16006187
Trends Immunol. 2009 Mar;30(3):124-30
pubmed: 19211304
Curr Drug Targets. 2011 Jun;12(7):1000-17
pubmed: 21366518
Cell. 1996 Sep 20;86(6):973-83
pubmed: 8808632
J Leukoc Biol. 2002 May;71(5):813-20
pubmed: 11994506
J Immunol. 2002 Jul 1;169(1):10-4
pubmed: 12077222
Mol Immunol. 2004 Jan;40(11):759-71
pubmed: 14687933
Vaccine. 2010 Jun 7;28(25):4153-61
pubmed: 20416262
Nat Med. 1997 Aug;3(8):849-54
pubmed: 9256274
Fish Shellfish Immunol. 2017 Sep;68:124-131
pubmed: 28698120
Science. 2004 Mar 5;303(5663):1529-31
pubmed: 14976261
Fish Shellfish Immunol. 2009 Mar;26(3):492-9
pubmed: 19340952
Fish Shellfish Immunol. 2018 Jan;72:646-657
pubmed: 29175443
J Fish Dis. 2013 Mar;36(3):229-40
pubmed: 23163585
Eur Cytokine Netw. 2000 Sep;11(3):372-8
pubmed: 11022120
Vaccine. 2018 Jan 29;36(5):668-674
pubmed: 29289383
Avian Dis. 2004 Dec;48(4):813-22
pubmed: 15666862
Annu Rev Biochem. 2007;76:447-80
pubmed: 17328678
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9237-42
pubmed: 11470918
Vaccine. 2014 Sep 29;32(43):5593-9
pubmed: 25131730
Dev Comp Immunol. 2007;31(1):39-51
pubmed: 16890289
Dev Comp Immunol. 2014 May;44(1):173-9
pubmed: 24333435
Dev Comp Immunol. 2016 Sep;62:72-81
pubmed: 27143535
Int Immunopharmacol. 2006 Oct;6(10):1586-96
pubmed: 16919831
Dev Comp Immunol. 2014 May;44(1):124-32
pubmed: 24333437
Science. 1999 Jul 30;285(5428):736-9
pubmed: 10426996
Nucleic Acids Res. 1988 Apr 25;16(8):3209-21
pubmed: 2836790
J Immunol. 2010 Jul 1;185(1):460-7
pubmed: 20498358
Mol Immunol. 2009 Sep;46(15):3163-70
pubmed: 19573927
Nature. 1997 Jul 24;388(6640):394-7
pubmed: 9237759
J Mol Recognit. 2018 Jun;31(6):e2696
pubmed: 29280512
Immunogenetics. 2013 Jul;65(7):511-30
pubmed: 23558557
J Immunol. 1999 Oct 1;163(7):3920-7
pubmed: 10490993
J Exp Med. 1997 Nov 17;186(10):1623-31
pubmed: 9362523
Fish Shellfish Immunol. 2008 Oct;25(4):341-50
pubmed: 18640057
Mol Immunol. 2010 Feb;47(5):1083-90
pubmed: 20004021
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2879-83
pubmed: 8610135
J Immunol. 1996 Sep 1;157(5):1840-5
pubmed: 8757300
Fish Shellfish Immunol. 2012 Sep;33(3):494-503
pubmed: 22683817
J Leukoc Biol. 2002 Mar;71(3):538-44
pubmed: 11867692
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):179-90
pubmed: 22129787
Fish Shellfish Immunol. 2017 Jul;66:466-479
pubmed: 28546018
Immunity. 2008 Aug 15;29(2):182-91
pubmed: 18701082
Fish Shellfish Immunol. 2012 Jun;32(6):1022-31
pubmed: 22554574
Mol Biol Rep. 2012 Sep;39(9):8965-75
pubmed: 22729906
Nature. 1995 Apr 6;374(6522):546-9
pubmed: 7700380
Semin Immunol. 2007 Feb;19(1):24-32
pubmed: 17275323
Fish Shellfish Immunol. 2013 Dec;35(6):1759-68
pubmed: 23769873
BMC Genomics. 2007 May 21;8:124
pubmed: 17517123

Auteurs

Chao-Yang Lai (CY)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Guann-Yi Yu (GY)

National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.

Yunping Luo (Y)

Deptartment of Immunology, Chinese Academy of Medical Science, School of Basic Medicine, Peking Union Medical College, Institute of Basic Medical Science, Beijing, China.
Collaborative Innovation Center for Biotherapy, School of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Rong Xiang (R)

Department of Immunology, School of Medicine, Nankai University, Tianjin, China.
International Joint Center for Biomedical Research of the Ministry of Education, Tianjin, China.

Tsung-Hsien Chuang (TH)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.
Program in Environmental and Occupational Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH